Author

Christopher D. Hart

St Vincent's Hospital Melbourne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Anne M. KongiD· 1 shared Ayeshah Augusta RosdahiD· 1 shared Brian G. DrewiD· 1 shared David W. GreeningiD· 1 shared Doan T M NgoiD· 1 shared Hei-Yi H. Woo· 1 shared Jarmon G. LeesiD· 1 shared Jessica K. HolieniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Anne M. KongORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

DRP1 inhibition confers cardioprotection against doxorubicin while preserving anticancer efficacy

Yali Deng, Sebastian Bass-Stringer, Simon T. Bond, Jonathon Cross, Jia Quyen Truong, Leonardo M. Hugen, Hei-Yi H. Woo, Ayeshah Augusta Rosdah, Anne M. Kong, Christopher D. Hart, Kylie L. Gorringe, Rebecca Helen Ritchie, Sanij Elaine, Brian G. Drew, David W. Greening, , Shiang Yong Lim

This paper shows DRP1 inhibition reduces doxorubicin-induced cardiotoxicity while maintaining its anticancer effects in multiple cancer models.

bioRxiv · Feb 17, 2026 · PreprintPharmacology & Toxicology